Invokamet

Active Ingredient(s): Canagliflozin + Metformin Hydrochloride
FDA Approved: * August 8, 2014
Pharm Company: * JANSSEN PHARMS
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Invokamet Overview

Canagliflozin (trade name Invokana or Sulisent) is a medication used for the treatment of type 2 diabetes.[1][2] It is of the gliflozin class or subtype 2 sodium-glucose transport (SGLT-2) inhibitors class. This mechanism is associated with a low risk of hypoglycaemia (too low blood glucose) compared to sulfonylurea derivatives and insulin.[3] In 2017, the FDA concluded that canagliflozin causes an increased risk of leg and foot amputations.&...

Read more Invokamet Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Canagliflozin

Recent Invokamet Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Canagliflozin + Metformin Hydrochloride
  • Tablet: 150mg + 1gm, 150mg + 500mg, 50/500 Mg. + 150/500 Mg. + 50/1000 Mg. + 150/1000 Mg., 50mg + 1gm, 50mg + 500mg
  • Tablet, Extended Release: 150mg + 1gm, 150mg + 500mg, 50mg + 1gm, 50mg + 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Invokamet: (4 results)

Sorted by National Drug Code
  • 50458-540 Invokamet Oral Tablet, Film Coated by Janssen Pharmaceuticals, Inc.
  • 50458-541 Invokamet Oral Tablet, Film Coated by Janssen Pharmaceuticals, Inc.
  • 50458-542 Invokamet Oral Tablet, Film Coated by Janssen Pharmaceuticals, Inc.
  • 50458-543 Invokamet Oral Tablet, Film Coated by Janssen Pharmaceuticals, Inc.

Drugs with one or more similar ingredients: (25 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA